- Incretin / Metabolic Research
Semaglutide
GLP-1 signaling, glycemic control, appetite, body weight, and cardiovascular outcomes
- Compound type
Long-acting GLP-1 receptor agonist peptide analog
- Research status
Semaglutide is an FDA-approved active ingredient in prescription drugs; Apex material is research-use-only and is not an approved drug product
- Scientific overview
Overview
Semaglutide is a long-acting analog of glucagon-like peptide-1 (GLP-1) designed for prolonged receptor activation. It has an extensive human clinical literature in type 2 diabetes, chronic weight management, and cardiovascular-risk research. Mechanistically, GLP-1 receptor activation influences glucose-dependent insulin secretion, glucagon signaling, appetite-related central pathways, and gastrointestinal motility. FDA approvals apply to specific manufactured prescription products such as Ozempic, Wegovy, and Rybelsus—not to separately sold research material.
How it works
GLP-1 receptor activation: Enhances glucose-dependent insulin signaling and suppresses inappropriate glucagon secretion.
Central appetite signaling: GLP-1 pathways in the brain influence hunger, satiety, and food intake.
Gastrointestinal signaling: The drug class can slow gastric emptying, especially during early exposure.
Research areas
Type 2 diabetes
Chronic weight management
Cardiovascular outcomes
Metabolic and liver-related research
Research / study context
STEP program: Large randomized obesity trials measured body weight, cardiometabolic markers, and safety.
SUSTAIN / cardiovascular programs: Diabetes and cardiovascular trials evaluated glycemic and major cardiovascular outcomes.
Key research findings
Semaglutide has one of the largest clinical evidence bases in this product list.
Benefits and risks are product- and indication-specific.
Apex RUO material must not be represented as Ozempic, Wegovy, Rybelsus, or a substitute for them.
Scientific reference starter set
Peptide Education Hub: Semaglutide profile
PubMed: STEP 1 semaglutide obesity trial
FDA prescribing information: Ozempic / Wegovy / Rybelsus
Research material
View available specifications and batch documentation in the Apex catalog.
Important
For research use only. Not for human consumption. This profile is educational and does not provide treatment or personal-use instructions.